Results 91 to 100 of about 10,864 (278)

Rosazea im Kindes‐ und Jugendalter

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 6, Page 684-692, June 2025.
Zusammenfassung Obwohl die Rosazea bei Kindern und Jugendlichen ähnliche Symptome, Auslöser und Verlaufsmuster wie bei Erwachsenen zeigt, wird sie in diesen Altersgruppen als Differenzialdiagnose häufig erst nachrangig in Betracht gezogen. Erstmanifestationen klassischer klinischer Typen können jedoch bereits ab dem Kleinkindalter beobachtet werden ...
Sören Korsing   +4 more
wiley   +1 more source

Difference in vasoconstrictors: oxymetazoline vs. brimonidine

open access: yesJournal of Dermatological Treatment, 2019
Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea. This review aims to investigate the efficacy, safety, pharmacodynamics, and pharmacokinetic properties of oxymetazoline and brimonidine.Phase II and phase III clinical studies evaluating oxymetazoline and brimonidine were assessed
Nwanneka Okwundu   +2 more
openaire   +3 more sources

Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop

open access: yesScientific Reports, 2017
The purpose of this study was to characterize and determine the efficacy of a long-term, non-invasive gel/microsphere (GMS) eye drop for glaucoma. This novel drug delivery system is comprised of a thermoresponsive hydrogel carrier and drug-loaded polymer
Morgan V. Fedorchak   +4 more
doaj   +1 more source

New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review. [PDF]

open access: yes, 2015
The horizon scanning review aimed to identify new and emerging technologies in development that have the potential to slow or stop disease progression and/or reverse sight loss in people with inherited retinal diseases (IRDs).
Michaelides, M   +4 more
core  

Glaucoma: Hot topics in Pharmacology [PDF]

open access: yes, 2017
BACKGROUND: Glaucoma comprises a group of neurodegenerative diseases resulting in retinal ganglion cell death within the optic nerve head. It is projected to affect almost 80 million people worldwide by 2020.
Balendra, SI   +4 more
core   +1 more source

Leber hereditary optic neuropathy: Current perspectives [PDF]

open access: yes, 2015
Leber hereditary optic neuropathy (LHON) is one of the most common inherited optic neuropathies causing bilateral central vision loss. The disorder results from point mutations in mitochondrial DNA and subsequent mitochondrial dysfunction.
McClelland, Collin   +2 more
core   +3 more sources

Prevention of Post‐Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 3, Page 119-126, May 2025.
ABSTRACT Background/Objectives Post‐inflammatory hyperpigmentation (PIH) impacts all skin tones with a heightened predilection for Fitzpatrick skin types (FST) III‐VI. Preventative measures include pre‐ and post‐intervention approaches, such as sunscreen and corticosteroids. This systematic review aims to summarise the preventative measure outcomes for
Kristie Mar   +5 more
wiley   +1 more source

Pre- and postsynaptic effects of brimonidine on isolated rabbit iris dilator muscles

open access: yesClinical Ophthalmology, 2016
Sonoko Tatsui,1 Hitoshi Ishikawa,2 Kimiya Shimizu,1 Kimiyo Mashimo1 1Department of Ophthalmology, School of Medicine, Kitasato University, 2Department of Orthoptics and Visual Sciences, School of Allied Health Sciences, Kitasato University, Sagamihara ...
Tatsui S   +3 more
doaj  

Prevention of intraocular pressure elevation after argon laser trabeculoplasty in primary open angle glaucoma [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2011
Introduction. Argon laser trabeculoplasty (ALT) is an intraocular pressure lowering method that is overall safe and powerful, but often complicated by transient postoperative intraocular pressure rises.
Božić Marija   +4 more
doaj   +1 more source

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]

open access: yes, 2019
There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm   +36 more
core   +2 more sources

Home - About - Disclaimer - Privacy